Researchers evaluate possible mitochondrial factors in Alzheimer’s pathogenesis

A group of authors critically evaluated and interpreted the evidence linking mitochondrial dysfunction and metabolic changes to the pathogenesis of Alzheimer’s disease (AD).

2024’s biopharma winners and losers; CagriSema falls short; Merck swings China GLP-1 deal; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 22, 2024

Maternal metabolic conditions linked to children’s neurodevelopmental risks, study shows

Study investigates how maternal metabolic conditions like pregestational diabetes, gestational diabetes, and obesity mediate the risk of neurodevelopmental conditions in children. It highlights the significant

November 13, 2023

Pfizer and Novartis chiefs lead pharma’s CEO influencers on social media, analysis finds

When it comes to pharma CEOs as social influencers, Pfizer’s Albert Bourla is a perfect 10 compared to his peers. Novartis CEO Vas Narasimhan is

February 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.